TherapeuticsMD, Inc. (TXMD) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 936K | 368K | 1.05M | 324K | 686K | 12K | -185K | 894K | 11K | -7.84M | -2.46M | -4.67M |
| Operating CF Margin % | 129.28% | 41.21% | 133.42% | 34.03% | 174.55% | 1.8% | -33.82% | 382.05% | 3.51% | -1561.95% | 4632.08% | -1068.65% |
| Operating CF Growth % | 36.44% | 2966.67% | 665.41% | -63.76% | 6136.36% | 100.15% | 92.46% | 119.14% | 100.03% | -113.12% | -123.57% | -104.03% |
| Net Income | 103K | -612K | 50K | 545K | -636K | 252K | -567K | -1.09M | -809K | -1.54M | -1.43M | -2.41M |
| Depreciation & Amortization | 325K | 906K | 96K | 96K | 95K | 100K | 96K | 180K | 133K | 637K | 130K | 128K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 24K | 0 | 96K | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -6K | -486K | 295K | 160K | 252K | -903K | 115K | 936K | 537K | -3.48M | 4.41M | -857K |
| Working Capital Changes | 514K | 560K | 605K | -477K | 975K | 539K | 171K | 772K | 150K | -3.46M | -5.56M | -1.53M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -340K | 114K | -87K | 174K | -82K | 0 | 91K | 4K | 112K | -669K | -812K | -818K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | 1561.95% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M | -1.11M | 1.15M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M | -1K | 1.15M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.11M | 1K |
| Net Change in Cash | 936K | 368K | 1.05M | 324K | 686K | 12K | -185K | 894K | 11K | -5.84M | -3.56M | -3.52M |
| Free Cash Flow | 936K | 368K | 1.05M | 324K | 686K | 12K | -185K | 894K | 11K | 0 | -2.46M | -4.67M |
| FCF Margin % | 129.28% | 41.21% | 133.42% | 34.03% | 174.55% | 1.8% | -33.82% | 382.05% | 3.51% | - | 4632.08% | -1068.65% |
| FCF Growth % | 36.44% | 2966.67% | 665.41% | -63.76% | 6136.36% | - | 92.46% | 119.14% | 100.03% | -100% | -123.57% | -104.03% |
| FCF per Share | 0.08 | 0.03 | 0.09 | 0.03 | 0.06 | 0.00 | -0.02 | 0.08 | 0.00 | - | -0.23 | -0.46 |
| FCF Conversion (FCF/Net Income) | 9.85x | -0.59x | 6.88x | 0.59x | -1.05x | 0.05x | 0.30x | -0.82x | -0.01x | 8.88x | 0.73x | 1.93x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |